Phase II Trial of Weekly Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: KTOSG Trial 1301

被引：0
|
作者：
Sakata, Shinya [1 ]
Saeki, Sho [1 ]
Okamoto, Isamu [2 ]
Otsubo, Kohei [2 ]
Komiya, Kazutoshi [3 ]
Morinaga, Ryotaro [4 ]
Yoneshima, Yasuto [2 ]
Koga, Yuichiro [2 ]
Enokizu, Aimi [2 ]
Kishi, Hiroto [5 ]
Hirosako, Susumu [1 ]
Yamaguchi, Emi [1 ]
Aragane, Naoko [3 ]
Fujii, Shinji [6 ]
Harada, Taishi [2 ]
Iwama, Eiji [2 ]
Nakanishi, Yoichi [2 ]
Kohrogi, Hirotsugu [1 ]
机构：
[1] Kumamoto Univ Hosp, Dept Resp Med, Kumamoto, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Fukuoka, Japan
[3] Saga Univ, Saga, Japan
[4] Oita Prefectural Hosp, Dept Resp Med & Oncol, Oita, Japan
[5] Kumamoto City Hosp, Dept Resp Med, Kumamoto, Japan
[6] Kumamoto Reg Med Ctr, Div Resp Dis, Kumamoto, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
non-small cell lung cancer; objective response rate; nab-paclitaxel; phase II trial;
D O I：
10.1016/j.jtho.2016.11.1266
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03a-056
引用
收藏
页码：S923 / S923
页数：1
相关论文
共 50 条
  • [31] Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: A phase II trial
    Gatzemeier, U
    Heckmayer, M
    Neuhauss, R
    Schluter, I
    vonPawel, J
    Wagner, H
    Dreps, A
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 24 - 28
  • [32] PHASE II TRIAL OF ERLOTINIB IN PREVIOUSLY TREATED PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Okano, Yoshio
    Shinohara, Tsutomu
    Machida, Hisanori
    Hatakeyama, Nobuo
    Takeuchi, Eiji
    Doi, Hiroyuki
    Kubota, Tetsuya
    Yokoyama, Akihito
    Ogushi, Fumitaka
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1175 - S1176
  • [33] Phase I/II trial of combination nab-paclitaxel and pemetrexed in advanced solid tumor patients (pts) with emphasis on non-small cell lung cancer (NSCLC).
    Riess, Jonathan
    Ho, Cheryl
    Davies, Angela M.
    Lau, Derick
    Lara, Primo
    Chew, Helen K.
    Beckett, Laurel
    Sangha, Randeep S.
    Mack, Philip C.
    Gandara, David R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naive patients with advanced non-small cell lung cancer
    Kono, Y.
    Hattori, Y.
    Nishino, K.
    Uozumi, R.
    Itoh, S.
    Inoue, T.
    Kumagai, T.
    Morita, S.
    Imamura, F.
    Satouchi, M.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S102 - S103
  • [35] A phase II trial of weekly paclitaxel and gemctiabine infused at a constant rate in patients with advanced non-small cell lung cancer
    Gillenwater, HH
    Stinchcombe, TE
    Qaqish, BF
    Tyann, M
    Hensing, TA
    Socinski, MA
    LUNG CANCER, 2005, 47 (03) : 413 - 419
  • [36] Phase I/II trial of weekly docetaxel and carboplatin in previously untreated patients with advanced non-small cell lung cancer
    Walsh, W
    Gordon, J
    Merolli, R
    Seidler, C
    Kasturi, V
    Finn, T
    Liu, Q
    Strauss, G
    LUNG CANCER, 2004, 46 : S63 - S63
  • [37] Phase III Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
    Nakamura, A.
    Yoneshima, Y.
    Morita, S.
    Ando, M.
    Iwasawa, S.
    Yoshioka, H.
    Goto, Y.
    Takeshita, M.
    Harada, T.
    Hirano, K.
    Oguri, T.
    Kondo, M.
    Miura, S.
    Hosomi, Y.
    Kato, T.
    Kubo, T.
    Kishimoto, J.
    Yamamoto, N.
    Nakanishi, Y.
    Okamoto, I.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S107 - S108
  • [38] A phase II trial of denileukin diftitox in patients with previously treated advanced non-small cell lung cancer (NSCLC).
    Lewis, MAG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 653S - 653S
  • [39] A phase II trial of denileukin difititox- in previously treated, advanced non-small cell lung cancer (NSCLC).
    Lewis, MAG
    Shukla, R
    Kleykamp, B
    Jazieh, AR
    Hainsworth, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 689S - 689S
  • [40] Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed
    Ciunci, Christine A.
    Reibel, Jacob B.
    Evans, Tracey L.
    Mick, Rosemarie
    Bauml, Joshua M.
    Aggarwal, Charu
    Marmarelis, Melina E.
    Singh, Aditi P.
    D'Avella, Christopher
    Cohen, Roger B.
    Langer, Corey J.
    CLINICAL LUNG CANCER, 2022, 23 (04) : E310 - E316
12345